BMA

BMA Biomedicals is a Swiss biotechnology company specializing in the development, manufacturing, and global distribution of high-quality immunological reagents. Founded in 1989 by a group of immunologists, the company focuses on producing monoclonal and polyclonal antibodies, as well as ELISA kits, primarily for in vitro research and diagnostic applications. BMA is recognized for its expertise in serum-free antibody production, which enhances experimental reproducibility and supports ethical manufacturing standards. The company's product portfolio targets key therapeutic areas including inflammation, hemostasis, infectious diseases, and tumor-related research. Since its acquisition by Chemoforma AG in 2005, BMA has expanded its reach and integrated the product lines of Peninsula Laboratories International to offer a comprehensive suite of immunochemical tools.